Mohammad Azam Selected Research

bisindolylmaleimide IX

10/2016

Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Azam Research Topics

Disease

21	Neoplasms (Cancer) 04/2021 - 01/2003
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 01/2003
6	Leukemia 01/2022 - 01/2004
2	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 07/2020
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 01/2019
2	Carcinogenesis 01/2019 - 07/2009
2	Hepatocellular Carcinoma (Hepatoma) 04/2016 - 09/2012
2	Infections 01/2009 - 06/2006
1	COVID-19 07/2022
1	Contact Dermatitis (Eczema, Contact) 11/2020
1	Neurofibrosarcoma (MPNST) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Necrosis 01/2019
1	Neurofibroma 01/2019
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Polycythemia (Erythrocytosis) 01/2018
1	Residual Neoplasm 04/2017
1	Osteosarcoma (Osteogenic Sarcoma) 04/2017
1	Oncogene Addiction 10/2016
1	Carcinoma (Carcinomatosis) 04/2016
1	Adenocarcinoma 04/2016
1	Mucositis 01/2014
1	Stomatitis 01/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2014
1	Unstable Angina 08/2011
1	Stable Angina 08/2011
1	Leiomyoma (Uterine Fibroids) 10/2010
1	Rhabdomyolysis 01/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2005
1	Philadelphia Chromosome 02/2005

Drug/Important Bio-Agent (IBA)

8	Imatinib Mesylate (Gleevec)FDA Link 12/2014 - 01/2003
7	Phosphotransferases (Kinase)IBA 07/2020 - 01/2003
6	Pharmaceutical PreparationsIBA 07/2022 - 01/2003
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2007
3	bcr-abl Fusion ProteinsIBA 04/2017 - 03/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 04/2017
2	PlatinumIBA 09/2020 - 07/2020
2	ibrutinibIBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2017
2	LigandsIBA 04/2016 - 09/2012
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2022
1	CarcinogensIBA 04/2021
1	Heavy MetalsIBA 04/2021
1	AllergensIBA 11/2020
1	Small Interfering RNA (siRNA)IBA 07/2020
1	Glutathione (Reduced Glutathione)IBA 07/2020
1	Antineoplastic Agents (Antineoplastics)IBA 07/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2020
1	Cytochromes c (Cytochrome c)IBA 07/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Guanosine Triphosphate (GTP)IBA 01/2019
1	Protein Phosphatase 1IBA 01/2019
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	Dual-Specificity PhosphatasesIBA 01/2019
1	CaspasesIBA 12/2018
1	Caspase 3 (Caspase-3)IBA 12/2018
1	Doxycycline (Periostat)FDA LinkGeneric 01/2018
1	Erythropoietin FDA Link 01/2018
1	Dual Specificity Phosphatase 1IBA 04/2017
1	bisindolylmaleimide IXIBA 10/2016
1	benzothiazoleIBA 04/2016
1	IsatinIBA 04/2016
1	Coordination ComplexesIBA 04/2016
1	Glutamine (L-Glutamine)FDA Link 01/2014
1	SuspensionsIBA 01/2014
1	disalicylaldehyde ethylenediamine (salen)IBA 09/2012
1	Immunoglobulin A (IgA)IBA 08/2011
1	Coloring Agents (Dyes)IBA 10/2010
1	AP 24163IBA 08/2009
1	MicroRNAs (MicroRNA)IBA 07/2009
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2009
1	ChemokinesIBA 04/2009
1	VaccinesIBA 04/2009
1	InterferonsIBA 04/2009
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 04/2009
1	Fusidic Acid (Fucithalmic)IBA 01/2009
1	Linezolid (Zyvox)FDA Link 01/2009
1	Atorvastatin (Lipitor)FDA Link 01/2009
1	Oncogene Proteins (Oncogene Protein)IBA 09/2007
1	AntigensIBA 06/2006
1	Urea (Carbamide)FDA LinkGeneric 06/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2006
2	Radiotherapy 09/2020 - 01/2014
1	Adjuvant Radiotherapy 09/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Hysterectomy 10/2010
1	Oral Administration 08/2009
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2004